Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Global Companion Animal Pharmaceuticals Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other)
4.2.2. By Animal (Dogs, Cats, Horses, Other)
4.2.3. By Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies, Others)
4.2.4. By Region
4.2.5. By Company (2023)
4.3. Market Map
4.3.1. By Indication
4.3.2. By Animal
4.3.3. By Distribution Channel
4.3.4. By Region

5. Asia Pacific Companion Animal Pharmaceuticals Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Indication
5.2.2. By Animal
5.2.3. By Distribution Channel
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Companion Animal Pharmaceuticals Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Indication
5.3.1.2.2. By Animal
5.3.1.2.3. By Distribution Channel
5.3.2. India Companion Animal Pharmaceuticals Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Indication
5.3.2.2.2. By Animal
5.3.2.2.3. By Distribution Channel
5.3.3. Australia Companion Animal Pharmaceuticals Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Indication
5.3.3.2.2. By Animal
5.3.3.2.3. By Distribution Channel
5.3.4. Japan Companion Animal Pharmaceuticals Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Indication
5.3.4.2.2. By Animal
5.3.4.2.3. By Distribution Channel
5.3.5. South Korea Companion Animal Pharmaceuticals Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Indication
5.3.5.2.2. By Animal
5.3.5.2.3. By Distribution Channel

6. Europe Companion Animal Pharmaceuticals Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Indication
6.2.2. By Animal
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Companion Animal Pharmaceuticals Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Indication
6.3.1.2.2. By Animal
6.3.1.2.3. By Distribution Channel
6.3.2. Germany Companion Animal Pharmaceuticals Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Indication
6.3.2.2.2. By Animal
6.3.2.2.3. By Distribution Channel
6.3.3. Spain Companion Animal Pharmaceuticals Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Indication
6.3.3.2.2. By Animal
6.3.3.2.3. By Distribution Channel
6.3.4. Italy Companion Animal Pharmaceuticals Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Indication
6.3.4.2.2. By Animal
6.3.4.2.3. By Distribution Channel
6.3.5. United Kingdom Companion Animal Pharmaceuticals Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Indication
6.3.5.2.2. By Animal
6.3.5.2.3. By Distribution Channel

7. North America Companion Animal Pharmaceuticals Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Animal
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Companion Animal Pharmaceuticals Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Indication
7.3.1.2.2. By Animal
7.3.1.2.3. By Distribution Channel
7.3.2. Mexico Companion Animal Pharmaceuticals Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Indication
7.3.2.2.2. By Animal
7.3.2.2.3. By Distribution Channel
7.3.3. Canada Companion Animal Pharmaceuticals Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Indication
7.3.3.2.2. By Animal
7.3.3.2.3. By Distribution Channel

8. South America Companion Animal Pharmaceuticals Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Animal
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Companion Animal Pharmaceuticals Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Indication
8.3.1.2.2. By Animal
8.3.1.2.3. By Distribution Channel
8.3.2. Argentina Companion Animal Pharmaceuticals Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Indication
8.3.2.2.2. By Animal
8.3.2.2.3. By Distribution Channel
8.3.3. Colombia Companion Animal Pharmaceuticals Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Indication
8.3.3.2.2. By Animal
8.3.3.2.3. By Distribution Channel
9. Middle East and Africa Companion Animal Pharmaceuticals Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Animal
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Companion Animal Pharmaceuticals Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Indication
9.3.1.2.2. By Animal
9.3.1.2.3. By Distribution Channel
9.3.2. Saudi Arabia Companion Animal Pharmaceuticals Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Indication
9.3.2.2.2. By Animal
9.3.2.2.3. By Distribution Channel
9.3.3. UAE Companion Animal Pharmaceuticals Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Indication
9.3.3.2.2. By Animal
9.3.3.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions

12. Global Companion Animal Pharmaceuticals Market: SWOT Analysis

13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape
14.1. Zoetis Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Product & Services
14.1.4. Financials (In case of listed)
14.1.5. Recent Developments
14.1.6. SWOT Analysis
14.2. Merck & Co., Inc.
14.3. Boehringer Ingelheim GmbH
14.4. Elanco Animal Health Incorporated
14.5. Ceva Sant? Animale
14.6. Virbac Corp.
14.7. Vetoquinol S.A.
14.8. Dechra Pharmaceuticals plc
14.9. Chanelle Pharma
14.10. Kyoritsu Seiyaku Corp.

15. Strategic Recommendations

16. About Us & Disclaimer